China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says

Investing.com Gold reports: China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says. Full body text was unavailable at ingest time, so this brief is based on headline context.